ZERONDA TYLER (Interim CFO) received a stock award from VYNE THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2022ACC: 0001209191-22-020067
Officer· Interim CFO
Since Jun 2021
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
85.9%
3/17/2022
87.33K→162.33K
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2022 | A · Award | +75K | — | — | 85.9% | 87.33K | 162.33K |
| Total | +75K | $0.00 | ||||||
Derivative Transactions1
Stock Options
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
0.61
Held after
75K
Exercisable
—
3/17/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock75K shares | 3/17/2022 | A · Award | +75K | 0.61 | — | 75K |